📰 Fergus Fleming News
Fergus Fleming News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fergus Fleming. Real-time updates on events, politics, business and more.
March 25, 2024
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
May 12, 2023
This week, we feature an urban planner’s engaging guide to building on Mars and a suspenseful novel about ...
April 6, 2023
Operator: Good morning and welcome to the Renalytix Conference Call to review Second Quarter and First Half Fiscal Year 2023 Financial Results.
January 26, 2023
Investegate announcements from Renalytix PLC, Renalytix and Partners Awarded $10 Million Grant
December 7, 2022
Operator: Good morning and welcome to the Renalytix Conference Call to review First Quarter Fiscal 2023 Financial Results. At this time, all participants are in a listen-only mode.
March 31, 2022
Investegate announcements from Renalytix PLC, $30.0 million financing package
March 29, 2022
NEW YORK and SALT LAKE CITY, March 29, 2022 -- Renalytix plc today announced the proprietary Renalytix Accelerating Precision medicine In Diabetes biorepository is on track to exceed 4,000... | March 29, 2022
April 15, 2021
Photo by SCIEPRO/Getty Images Clinical diagnostic company Renalytix AI has expanded its partnership with the Joslin Diabetes Center to integrate new biomarkers for kidney disease discovered by the centers researchers into the company’s KidneyIntelX platform. KidneyIntelX is an in vitro diagnostic platform that assesses the risk of adverse kidney outcomes in patients with Type 2 diabetes and early-stage kidney disease. By examining a patient’s blood sample and medical history, the diagnostic...
April 14, 2021
surrounding a comprehensive panel of novel biomarkers in kidney disease NEW YORK, April 14, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announced today that it has entered into an exclusive option agreement with Joslin Diabetes Center for patent filings on certain additional novel biomarkers in kidney disease for development and deployment in the KidneyIntelX in vitro prognostic platform. These novel biomarkers have the p...
April 14, 2021
TRADING UPDATES: Rainbow Rare Earths Burundi exports suspended Wed, 14th Apr 2021 21:40 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Rainbow Rare Earths Ltd - rare earth metals projects in Burundi and South Africa - Notes suspension order from Burundi government on the export of concentrate produced from trial mining and processing operations at its Gakara project in Burundi, which is focue...